← back to search

Juan Iovanna

Inserm · FR
🔎 Find collaborators in Oncology · Surgery →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Cancer Genomics and Diagnostics, and Epigenetics and DNA Methylation.
h-index
86
citations
37,076
works
705
NIH funding
primary concept
email

Recent publications

A guideline on the molecular ecosystem regulating ferroptosis
Nature Cell Biology 2024cited by 238position: middledoi
Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
iScience 2023cited by 20position: middledoi
Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression
The EMBO Journal 2022cited by 68position: middledoi
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?
Therapeutic Advances in Medical Oncology 2019cited by 37position: middledoi
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Cellular Immunology 2018cited by 274position: middledoi
Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
Nature Communications 2017cited by 401position: middledoi
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
Gut 2016cited by 273position: middledoi
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness
Journal of Clinical Investigation 2016cited by 210position: middledoi
A liver stress-endocrine nexus promotes metabolic integrity during dietary protein dilution
Journal of Clinical Investigation 2016cited by 168position: middledoi
Germline copy number variation in the<i>YTHDC2</i>gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?
Expert Opinion on Therapeutic Targets 2014cited by 47position: middledoi
Genetic inactivation of<i>Nupr1</i>acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis
Gut 2013cited by 39position: lastdoi
Homotypic cell cannibalism, a cell‐death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
EMBO Molecular Medicine 2012cited by 88position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Nelson Dusetti · Inserm5 papers (2013–2023) · 4 papers (2012–2017) · 3 papers (2016–2022) · 3 papers (2016–2022) · 3 papers (2017–2023)Antonio Russo · Sandia National Laboratories3 papers (2014–2019) · 3 papers (2016–2023) · 3 papers (2012–2016) · 3 papers (2012–2017) · 3 papers (2014–2019) · 3 papers (2017–2023) · 3 papers (2014–2019) · 3 papers (2016–2022)Victoire Gouirand · University of California, San Francisco2 papers (2017–2022)Bruno Vincenzi · Università Campus Bio-Medico2 papers (2018–2019)Laurent Bartholin · Université Claude Bernard Lyon 12 papers (2012–2013) · 2 papers (2017–2022)Julie Leca · Centre de Recherche en Neurobiologie - Neurophysiologie de Marseille2 papers (2016–2022)Jared R. Mayers · Massachusetts Institute of Technology2 papers (2017–2022)Carla E. Cano · Tufts University2 papers (2012–2013)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Surgery →